25 August, 2020
The ARANZ Medical services team has an enviable reputation for exceeding customer expectations, and we have now added new data review services to help our clinical trial customers ensure they are getting the best data possible throughout their trial.
The new ARANZ Medical data review services help to remove biases in the collection of data and ensure that sites are following their trial protocols correctly. The new services include data blinding and providing independent expert assessors, who are trained in the use of Silhouette, to check the quality of the trial data that is being gathered.
Tom Rochford, ARANZ Medical’s VP Operations and Engineering says, “These new services are really making a difference for our clinical research customers. Now we can provide sponsors with timely feedback on their sites’ image quality and measurement accuracy. If issues are identified by the independent assessors, then adjustments can be quickly made to their data capture processes to keep the trial on track.”
Silhouette has been used in more than 165 clinical trials over the last 13 years. Now with these new service offerings, ARANZ Medical is able to provide sponsors with additional peace of mind that their data is being collected correctly. Promore Pharma’s Chief Scientific Officer, Prof. Margit Mahlapuu says, “There was no room for any errors in the way we gathered or reported the data. So, having the ability to have the data checked and validated by an independent assessor was key to our decision to use Silhouette.”
ARANZ Medical provides a range of services for our clinical research customers. We pride ourselves on our ability to deliver valuable insights on how to optimize your trial data collection, collaborating with your team throughout your trial and providing data review services to ensure you get the best quality data. For more information about these services, download our brochure or read more online.
Doc Number: 2020-00113
